The law under consideration “delinks” PBM compensation from manufacturer rebates in Medicare and requires flat administrative fees, certified at fair market value. It also mandates that rebates be passed through to health plan sponsors in the employer-sponsored market. This sounds appealing, but incentives matter. When compensation no longer depends on securing better terms, bargaining effort becomes a cost center rather than a profit center. PBMs will still compete for contracts, but competition on administrative fees isn’t the same as competition on aggressive price concessions and won’t lower drug prices.
原来夸克、通义千问本属于不同业务线，而灵光、阿福更是分属不同集团。阿里要想整合，势必要大动干戈，现阶段可能还有心无力。
。业内人士推荐体育直播作为进阶阅读
locks are unlocked, any complex data structures are in a reliable state,
Несколько беспилотников атаковали топливные резервуары в порту Дукм на востоке Омана. Об этом сообщает газета Times of Oman.